Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-003269
Filing Date
2025-01-22
Accepted
2025-01-22 17:28:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7593
  Complete submission text file 0001493152-25-003269.txt   9298
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Subject) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94055 | Film No.: 25546969
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)

Mailing Address C/O KARAM & MISSICK, ATTORNEYS 203/4 REGENT VILLAGE PROVIDENCIALES, GRACE BAY W7 TKCAZZI
Business Address C/O KARAM & MISSICK, ATTORNEYS 203/4 REGENT VILLAGE PROVIDENCIALES, GRACE BAY W7 TKCAZZI 1-649-941-5082
GREENFIELD INVESTMENTS LTD. (Filed by) CIK: 0002052615 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G